565 related articles for article (PubMed ID: 16953149)
21. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood.
Deback C; Fillet AM; Dhedin N; Barrou B; Varnous S; Najioullah F; Bricaire F; Agut H
J Clin Virol; 2007 Nov; 40(3):173-9. PubMed ID: 17904901
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
23. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
[TBL] [Abstract][Full Text] [Related]
24. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG
Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
[TBL] [Abstract][Full Text] [Related]
27. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens.
Madhavan HN; Sowmya P; Therese KL; Malathi J
J Virol Methods; 2007 May; 141(2):166-72. PubMed ID: 17222918
[TBL] [Abstract][Full Text] [Related]
28. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
[TBL] [Abstract][Full Text] [Related]
29. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
[TBL] [Abstract][Full Text] [Related]
30. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
[No Abstract] [Full Text] [Related]
31. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
32. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR.
Madi N; Al-Nakib W; Mustafa AS; Saeed T; Pacsa A; Nampoory MR
Med Princ Pract; 2007; 16(4):268-73. PubMed ID: 17541291
[TBL] [Abstract][Full Text] [Related]
33. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
[TBL] [Abstract][Full Text] [Related]
34. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
35. Monitoring of human cytomegalovirus glycoprotein B genotypes using real-time quantitative PCR in immunocompromised Chinese patients.
Fan J; Zhang X; Chen XM; Gao HN; Yang MF; Zhao H; Hu JH; Ma WH
J Virol Methods; 2009 Sep; 160(1-2):74-7. PubMed ID: 19406161
[TBL] [Abstract][Full Text] [Related]
36. [Comparison between the LightCycler CMV Quant Kit (Roche Diagnostics) with a standardized in-house Taqman assay for cytomegalovirus blood viral load quantification].
Alain S; Lachaise V; Hantz S; Denis F
Pathol Biol (Paris); 2010 Apr; 58(2):156-61. PubMed ID: 19875243
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of three polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of human cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India.
Sowmya P; Madhavan HN; Therese KL
Virol J; 2006 Mar; 3():20. PubMed ID: 16571138
[TBL] [Abstract][Full Text] [Related]
38. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test.
Abbate I; Finnstrom N; Zaniratti S; Solmone MC; Selvaggini S; Bennici E; Neri S; Brega C; Paterno M; Capobianchi MR
J Virol Methods; 2008 Jul; 151(1):61-5. PubMed ID: 18462815
[TBL] [Abstract][Full Text] [Related]
40. [Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children].
Chen F; He Z; Pan S; Ning F; Wang Q; Xiao Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):187-90. PubMed ID: 12196838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]